C
Can-Fite BioPharma Ltd.
Q1 2025 earnings expected
Quarter
Jan – Mar
Expected
May 15, 2025(ET)
Revenue
This quarter$0M
Year ago (Mar '24)$0M▼ -36.1%
EPS
This quarter-$0.21
Analyst estimate-$0.24▲ +10.7%
Year ago (Mar '24)-$6.20▲ +96.5%
Revenue Growth Trajectory
-43%YoY
Last 6 quarters · 1 analysts